11 results
8-K
EX-99.1
TRML
Tourmaline Bio Inc
14 Dec 23
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
8:27am
cancer therapies, and grew to over $2 billion in annual revenue. During his tenure, he raised well over $1 billion in financing for Seagen from public
S-4
EX-3.3
TRML
Tourmaline Bio Inc
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
designated by the Board of Directors.
Section 29. Tenure and Duties of Officers.
(a) General. All officers will hold office at the pleasure of the Board
DEF 14A
TRML
Tourmaline Bio Inc
29 Apr 22
Definitive proxy
4:24pm
. Ildstad is also the founding director of the Institute for Cellular Therapeutics of the University of Louisville and is a Professor (with Tenure … tenure, he has participated in several drug development programs resulting in successful regulatory approvals, such as CTL-019 in pediatric ALL, the first
8-K
EX-3.2
ht0dl9
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
kyq6r3woy8
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
muh9x6
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
yioy530
3 May 21
IPO registration (amended)
6:07am
S-1
wm5fwxptb
16 Apr 21
IPO registration
5:03pm
DRS/A
bf1 vuwgle3swa
1 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next